Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01084252
Title Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi
Indications

acute myeloid leukemia

multiple myeloma

B-cell lymphoma

chronic lymphocytic leukemia

B-cell adult acute lymphocytic leukemia

Therapies

Isatuximab

Dexamethasone + Isatuximab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL


No variant requirements are available.